glp 1 weight loss results by week Before and after GLP-1: what the actually look like WEEK 12 UPDATE (on a

V.TsaturovaK

A study of 185,066 people with type 2 diabetes found that those taking a GLP-1 receptor agonist had a slightly higher risk of developing diabetic retinopathy but a lower likelihood of serious complications such as vision loss ( JAMA Network Open , Aug

No sugar

The studies were evenly distributed between Europe and the USA, with 4 studies conducted in each region

Novel immunotherapy combinations with chemotherapy or targeted agents/tyrosine kinase inhibitors are being assessed and developed for multiple indications that will add another layer of complexity to adverse events and their management

Rivus Pharmaceuticals Sector: Oral muscle-sparing therapeutics for obesity and metabolic liver disease HQ: Charlottesville, VA Year Founded: 2019 Origin Story: Rivus Pharmaceuticals was founded around the science of mitochondrial uncoupling, a natural process by which the body dissipates energy by burning fat and sugar without the muscle loss associated with caloric restriction or appetite-suppressing drugs